<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-619" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Aortic Valve Endocarditis Surgical Treatment</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Sarah A.</given-names>
          </name>
          <aff>Saint Francis Medical Group</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shlofmitz</surname>
            <given-names>Evan</given-names>
          </name>
          <aff>MedStar Washington/Georgetown University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sanjeev</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khalid</surname>
            <given-names>Nauman</given-names>
          </name>
          <aff>MedStar Washington Hospital Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarah Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Evan Shlofmitz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjeev Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nauman Khalid declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-619.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Aortic valve endocarditis surgical treatment involves a complex and high-risk procedure to eradicate infection and restore valve function. Surgery is typically indicated in cases of severe valve dysfunction, abscess formation, heart failure, or uncontrolled infection despite antibiotic therapy. The procedure may include valve repair or replacement, depending on the extent of damage to the valve and surrounding tissues. Early surgical intervention, combined with a multidisciplinary approach involving cardiologists, infectious disease specialists, and surgeons, has improved outcomes by addressing the structural damage caused by infection and the underlying pathogen.</p>
        <p>Clinicians participating in this course gain a comprehensive understanding of the latest guidelines, strategies, and techniques for managing aortic valve endocarditis. This includes the decision-making process for surgical intervention, the role of multidisciplinary endocarditis teams, and the importance of timely diagnosis and treatment. Participants enhance their knowledge of the pathophysiology of endocarditis, the use of advanced imaging and diagnostic tools, and the best practices for postoperative care, all aimed at improving patient outcomes and reducing the risk of complications.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between candidates for urgent, emergent, or elective aortic valve surgery based on clinical presentations and diagnostic findings.</p></list-item><list-item><p>Identify patients with aortic valve endocarditis who are at high risk and may benefit from surgical intervention.</p></list-item><list-item><p>Implement evidence-based protocols for the preoperative and postoperative management of patients undergoing aortic valve surgery for endocarditis.</p></list-item><list-item><p>Coordinate care between surgical, medical, and support teams to optimize postoperative recovery and long-term outcomes for patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=619&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=619">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-619.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Infective endocarditis (IE) is an infectious disease that primarily affects the endocardial surface of the heart, with the heart valves being the most common targets and the mural endocardium less frequently involved.<xref ref-type="bibr" rid="article-619.r1">[1]</xref><xref ref-type="bibr" rid="article-619.r2">[2]</xref> Classified as acute, subacute, or chronic depending on symptom onset and duration, IE remains a significant public health concern. In 2019, the global incidence of IE was estimated at 13.8 cases per 100,000 people annually, contributing to 66,300 deaths worldwide. The disease burden amounts to 1723.59 disability-adjusted life years and 0.87 deaths per 100,000 population&#x02014;ongoing research has centered on identifying the most effective prevention strategies.<xref ref-type="bibr" rid="article-619.r3">[3]</xref></p>
        <p>Over the past few decades, the incidence of IE has risen in the United States and globally, with <italic toggle="yes">Staphylococcus aureus</italic> now the predominant causative organism. Despite optimal medical management, mortality remains unacceptably high, prompting a focus on early recognition and intervention. Surgical management becomes critical for patients not responsive to medical therapy or those with complications, emphasizing the need for timely decision-making.</p>
        <p>IE of the aortic valve poses unique surgical challenges and is associated with high rates of mortality and complications, particularly in cases complicated by annular abscesses. The incidence of&#x000a0;aortic valve endocarditis complicated by annular abscess ranges from 12% to 50%, and its presence is a strong predictor of short-term mortality&#x02014;reported to be nearly twice as high compared to patients without abscesses.<xref ref-type="bibr" rid="article-619.r4">[4]</xref> Furthermore, the likelihood of recurrent endocarditis significantly increases in those with annular abscess formation.<xref ref-type="bibr" rid="article-619.r5">[5]</xref> Complete surgical debridement and abscess removal are critical to minimizing recurrence risk; this approach often results in tissue deficiencies, necessitating advanced reconstructive techniques like annular patch reconstruction to support prosthetic valve placement.<xref ref-type="bibr" rid="article-619.r6">[6]</xref> Additional strategies have been proposed to reduce recurrence rates further and enhance outcomes, such as using local antibiotics within the residual abscess cavity.<xref ref-type="bibr" rid="article-619.r7">[7]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-619.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>For native valve endocarditis and IE, the most common microorganisms are <italic toggle="yes">Streptococcus viridans</italic> and <italic toggle="yes">S aureus</italic>.<xref ref-type="bibr" rid="article-619.r1">[1]</xref> For prosthetic valve endocarditis in the early phase (less than&#x000a0;2 months), typical agents include coagulase-negative staphylococci,&#x000a0;<italic toggle="yes">Staphylococcus epidermidis (</italic>30%-35%), and&#x000a0;<italic toggle="yes">S aureus</italic>&#x000a0;(20%-24%). In the late phase (more than 12 months), the typical etiologic agents&#x000a0;are&#x000a0;<italic toggle="yes">S viridans</italic> and <italic toggle="yes">S aureus</italic>.<xref ref-type="bibr" rid="article-619.r1">[1]</xref> For acute bacterial endocarditis, the most common agent is <italic toggle="yes">S aureus</italic>, whereas for subacute&#x000a0;bacterial endocarditis, the most common agent is <italic toggle="yes">Streptococcus mutans</italic>.</p>
        <p>Candidal infectious endocarditis usually presents in patients with prosthetic valves, those who use intravenous drugs, and immunocompromised individuals.<xref ref-type="bibr" rid="article-619.r1">[1]</xref> Gastrointestinal or genitourinary manipulation&#x000a0;is a risk factor for <italic toggle="yes">Streptococcus bovis</italic>&#x000a0;or enterococcal&#x000a0;IE. Poor dental hygiene&#x000a0;risks streptococci and the HACEK group agents (<italic toggle="yes">Haemophilus</italic>, <italic toggle="yes">Aggregatibacter</italic>&#x000a0;[previously <italic toggle="yes">Actinobacillus</italic>], <italic toggle="yes">Cardiobacterium</italic>, <italic toggle="yes">Eikenella</italic>, <italic toggle="yes">Kingella</italic>). In contrast, nosocomial agents include <italic toggle="yes">S aureus</italic>, gram-negative agents, and <italic toggle="yes">Candida</italic> spp.&#x000a0;</p>
      </sec>
      <sec id="article-619.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epidemiological studies indicate that the profile of IE has shifted significantly worldwide. <italic toggle="yes">S aureus</italic> has emerged as the most common causative organism, supplanting previously predominant pathogens. Additionally, the demographic and clinical characteristics of affected patients have evolved, with an increased mean age, a higher proportion of prosthetic valve infections, and a greater number of surgeries performed for IE management.<xref ref-type="bibr" rid="article-619.r8">[8]</xref> There has also been a noticeable rise in IE incidence following minimally invasive aortic valve surgeries and percutaneous transcatheter aortic valve replacement procedures, highlighting the need for vigilant postprocedural monitoring and tailored management strategies.<xref ref-type="bibr" rid="article-619.r9">[9]</xref><xref ref-type="bibr" rid="article-619.r10">[10]</xref></p>
      </sec>
      <sec id="article-619.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>IE of the aortic valve is a life-threatening condition caused by microorganisms, most commonly bacteria, colonizing and subsequently infecting the valvular endocardial surface. The pathophysiology of aortic valve&#x000a0;endocarditis involves a complex interplay between endothelial injury, microbial adherence, immune response, and structural damage.</p>
        <p>
<bold>Endothelial Injury and Microbial Adherence</bold>
</p>
        <p>Endothelial injury, often caused by turbulent blood flow from congenital or acquired valve abnormalities such as a bicuspid aortic valve, aortic stenosis, or insufficiency, exposes the subendothelial collagen and tissue factor. This injury initiates the formation of a nonbacterial thrombotic endocardial lesion, which consists of fibrin and platelets. These lesions provide an ideal site for bacterial adhesion. Bacteremia, often resulting from dental, surgical, or other invasive procedures, allows circulating pathogens, particularly <italic toggle="yes">S aureus, S viridans, </italic>or<italic toggle="yes">&#x000a0;</italic>enterococci, to attach to the nonbacterial thrombotic endocardial lesion.</p>
        <p>
<bold>Colonization and Vegetation Formation</bold>
</p>
        <p>Once adhered, bacteria become encased in a fibrin and platelet matrix, forming vegetations. This environment shields the bacteria from immune surveillance and antibiotics, making the infection more difficult to eradicate. In aortic valve endocarditis, vegetation typically forms on the aortic side of the valve leaflets. As the vegetation grows, it can cause mechanical destruction of the valve, leading to aortic regurgitation or stenosis, further compromising hemodynamic function.</p>
        <p>
<bold>Immune Response and Tissue Damage</bold>
</p>
        <p>The host immune response to infection exacerbates the damage. Neutrophils and macrophages release inflammatory cytokines and proteolytic enzymes, contributing to local tissue destruction and weakening of the aortic valve. Over time, the infection may extend beyond the valve leaflets to the adjacent myocardium and aortic root, leading to complications such as ring abscesses, perivalvular leaks, or fistulae between cardiac chambers or the aorta.</p>
        <p>
<bold>Complications and Embolization</bold>
</p>
        <p>The vegetations can embolize, particularly in cases of large, friable vegetations, leading to systemic embolic events such as stroke, myocardial infarction, or embolism to peripheral organs (eg, kidneys, spleen). Additionally, severe aortic regurgitation due to valve destruction can cause acute heart failure, which is a frequent indication for urgent surgical intervention.</p>
      </sec>
      <sec id="article-619.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>IE remains challenging to diagnose due to its diverse clinical presentations. Consideration should be given to IE in any patient with sepsis or an unexplained fever, particularly when risk factors are present. Manifestations can vary widely, appearing as an acute, rapidly progressing infection or a subacute or chronic condition with mild or absent fever and vague symptoms, complicating the initial diagnosis. Furthermore, IE may present with complications that mimic various medical conditions, including rheumatologic, neurological, and autoimmune disorders or even malignancies. These diverse presentations can lead to evaluations for other diseases before arriving at an IE diagnosis. Maintaining a high level of suspicion for IE is crucial,&#x000a0;especially when fever and positive blood cultures are present without a clear source of infection. Early involvement of a multidisciplinary endocarditis team is strongly recommended to guide disease management.</p>
        <p>Data from the European Infective Endocarditis Registry reveal that the most common clinical signs of IE include fever (77.7%), heart murmur (64.5%), and heart failure (27.2%).<xref ref-type="bibr" rid="article-619.r11">[11]</xref>&#x000a0;Embolic complications were present&#x000a0;in 25.3% of patients, while cardiac conduction abnormalities were found in 11.5%.<xref ref-type="bibr" rid="article-619.r4">[4]</xref> Although classic peripheral stigmata, such as splinter hemorrhages and Osler nodes, are less frequently seen today, they may still occur in severe infections caused by <italic toggle="yes">S aureus</italic> or subacute IE, typically due to <italic toggle="yes">Streptococcus</italic> spp. Vascular and immunological manifestations, such as Roth spots and glomerulonephritis, remain common.<xref ref-type="bibr" rid="article-619.r12">[12]</xref></p>
        <p>Atypical presentations are more frequent in elderly or immunocompromised individuals, necessitating a high index of suspicion and a low threshold for testing to rule out IE, especially in high-risk groups like those with congenital heart disease or prosthetic valves.<xref ref-type="bibr" rid="article-619.r13">[13]</xref>&#x000a0;Educating these patients about their risk and the symptoms of IE is crucial so they can seek timely advice from specialized centers.<xref ref-type="bibr" rid="article-619.r14">[14]</xref>&#x000a0;The most common symptoms include fever, anorexia, weight loss, malaise, and night sweats.<xref ref-type="bibr" rid="article-619.r1">[1]</xref> Physical examination findings often reveal a murmur, petechiae on the skin, oral mucosa or conjunctivae, and splenomegaly.<xref ref-type="bibr" rid="article-619.r1">[1]</xref> Peripheral findings of IE include splinter hemorrhages, usually seen under the fingernails or toenails, as well as Osler nodes and Janeway lesions.<xref ref-type="bibr" rid="article-619.r1">[1]</xref></p>
      </sec>
      <sec id="article-619.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of IE is primarily based on clinical suspicion, supported by microbiological evidence and imaging that confirms cardiac lesions related to IE. A critical diagnostic criterion is detecting the involvement of the heart valves (native or prosthetic) or intracardiac prosthetic material. Echocardiography is the preferred initial imaging method. However, additional techniques such as computed tomography (CT) scans, positron emission tomography (PET), and magnetic resonance imaging (MRI) are increasingly incorporated into the diagnostic approach due to their ability to confirm IE, evaluate local complications, detect distant lesions, and trace the source of bacteremia in patients with secondary IE. Moreover, imaging findings play a crucial role in determining prognosis.<xref ref-type="bibr" rid="article-619.r15">[15]</xref></p>
        <p>The classification of IE is based on the Modified Duke Criteria, which provides a structured framework for evaluating patients suspected of having IE. The criteria classify cases into&#x000a0;3 categories: definite, possible, and rejected.<xref ref-type="bibr" rid="article-619.r16">[16]</xref> Definite IE can be further subdivided into&#x000a0;2 types:</p>
        <list list-type="bullet">
          <list-item>
            <p>Definite IE by pathological criteria
<list list-type="bullet"><list-item><p>Definite IE by pathological criteria is confirmed when microorganisms are identified in an excised vegetation or an abscess specimen or if histological evidence shows active endocarditis within the vegetation or abscess.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Definite IE by clinical criteria
<list list-type="bullet"><list-item><p>Definite IE by clinical criteria is met when&#x000a0;2 major criteria,&#x000a0;1 major criterion plus&#x000a0;3 minor criteria, or&#x000a0;5 minor criteria are fulfilled according to the Modified Duke Criteria.<xref ref-type="bibr" rid="article-619.r16">[16]</xref><xref ref-type="bibr" rid="article-619.r17">[17]</xref><xref ref-type="bibr" rid="article-619.r18">[18]</xref>
<list list-type="bullet"><list-item><p>The primary clinical criteria include:
<list list-type="bullet"><list-item><p>Multiple positive blood cultures</p></list-item><list-item><p>A single positive culture for <italic toggle="yes">Coxiella burnetii</italic></p></list-item><list-item><p>Evidence of endocardial involvement, such as new valvular regurgitation or echocardiographic findings of vegetation, abscess, or dehiscence&#x000a0;<xref ref-type="bibr" rid="article-619.r18">[18]</xref></p></list-item></list>
</p></list-item><list-item><p>Minor clinical criteria encompass the following:
<list list-type="bullet"><list-item><p>Predisposing heart conditions or intravenous drug use</p></list-item><list-item><p>Fever greater than 38 &#x000b0;C (100.4 &#x000b0;F)</p></list-item><list-item><p>Vascular phenomena like arterial emboli, septic pulmonary infarcts, or Janeway lesions</p></list-item><list-item><p>Immunologic phenomena such as Osler nodes, Roth spots, or rheumatoid factor</p></list-item><list-item><p>Positive blood cultures that do not meet the significance criteria&#x000a0;<xref ref-type="bibr" rid="article-619.r18">[18]</xref></p></list-item></list>
</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Possible IE is diagnosed when&#x000a0;1 major criterion and&#x000a0;1 minor criterion, or&#x000a0;3 minor criteria, are present.<xref ref-type="bibr" rid="article-619.r16">[16]</xref> Rejected IE is defined when an alternative diagnosis is more likely, there is no pathological evidence of IE after less than&#x000a0;4 days of antibiotic therapy, or clinical symptoms resolve within&#x000a0;4 days of antibiotic therapy.<xref ref-type="bibr" rid="article-619.r16">[16]</xref> The echocardiographic criteria for IE include an oscillating intracardiac mass on valves or supporting structures in the path of regurgitant jets, an abscess, or partial prosthetic valve dehiscence.<xref ref-type="bibr" rid="article-619.r16">[16]</xref> A transthoracic echocardiogram (TTE) should be corroborated by a transesophageal echocardiogram (TEE) to evaluate suspected IE comprehensively. In cases where no definitive diagnosis is established until surgery, tissue specimens should be obtained for histological analysis to confirm the presence of endocarditis.</p>
        <p>Advanced imaging modalities, such as CT, MRI, and&#x000a0;positron emission tomography-computed tomography (PET-CT), are highly recommended in patients with suspected or confirmed IE due to their ability to provide comprehensive diagnostic information. Cardiac CT is particularly valuable for diagnosing IE and its cardiac complications, including perivalvular and periprosthetic abscesses, pseudoaneurysms, and fistulas. Study results indicate that cardiac CT offers superior accuracy compared to TEE in detecting these complications, especially in cases of native valve endocarditis and prosthetic valve endocarditis when TEE is inconclusive or not feasible. Cardiac CT is also crucial in guiding surgical decisions, offering detailed anatomical views that inform the extent of surgical resection or reconstruction needed.<xref ref-type="bibr" rid="article-619.r19">[19]</xref></p>
        <p>Whole-body and brain CT are essential tools for detecting distant lesions and sources of bacteremia. These imaging studies allow clinicians to identify systemic complications of IE, such as septic emboli, which serve as minor diagnostic criteria and can contribute to establishing a definitive diagnosis or excluding IE. Furthermore, MRI&#x000a0;is indispensable in detecting neurological complications and spinal lesions related to IE.&#x000a0;The high-resolution imaging capability of MRI makes it ideal for evaluating ischemic or hemorrhagic strokes, which are often observed in patients with IE with septic embolization to the brain.<xref ref-type="bibr" rid="article-619.r20">[20]</xref></p>
        <p>Integrating PET-CT with CT angiography (PET/CTA) provides a novel approach for assessing IE's metabolic activity and anatomical abnormalities. The combination of fluorodeoxyglucose F 18 uptake measurement with anatomical visualization enables the detection of active infection sites and distant embolic events, aiding in the management of complex cases, such as those with congenital heart disease or aortic grafts. This multimodal imaging approach improves diagnostic precision and influences therapeutic strategies, ultimately optimizing patient outcomes.<xref ref-type="bibr" rid="article-619.r21">[21]</xref></p>
      </sec>
      <sec id="article-619.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management of IE primarily involves prolonged courses of bactericidal antibiotics. The choice of regimen, whether single or combination therapy and the duration of treatment (ranging from 2 to 6 weeks) depend on the pathogen&#x02019;s susceptibility and resistance profile and whether the patient has native or prosthetic valve endocarditis. Treatment typically begins in the hospital and is often completed on an outpatient basis once the patient is afebrile and blood cultures are negative. However, antibiotic therapy may not be sufficient for all cases. Surgery becomes necessary under Class I indications, which include valvular dysfunction leading to heart failure, left-sided IE caused by <italic toggle="yes">S aureus</italic>, fungal or resistant microorganisms, conduction abnormalities such as heart block, annular or abscess formation, or persistent infection after 5 to 7 days of antibiotic therapy.<xref ref-type="bibr" rid="article-619.r2">[2]</xref></p>
        <p>Surgical management of IE focuses on aggressive debridement of all infected and necrotic tissue, followed by reconstructive surgery. Intraoperative TEE is a Class I recommendation for evaluating the extent of damage.<xref ref-type="bibr" rid="article-619.r2">[2]</xref> With some exceptions, median sternotomy is also a Class I&#x000a0;recommendation.<xref ref-type="bibr" rid="article-619.r2">[2]</xref>&#x000a0;Surgical access to the aortic valve is typically achieved through a low transverse or oblique aortotomy. For native valve IE, the goal is to eradicate infected tissue and repair or replace the valve. Repair should be prioritized when infection is limited to the valve leaflets or cusps (Class I).<xref ref-type="bibr" rid="article-619.r2">[2]</xref> In cases requiring replacement, valve selection&#x02014;whether mechanical or bioprosthetic&#x02014;follows standard criteria (Class I), except in patients with contraindications such as intracranial hemorrhage or stroke (Class IIa).<xref ref-type="bibr" rid="article-619.r2">[2]</xref></p>
        <p>For native aortic valve endocarditis involving the annulus, radical resection of infected tissue is crucial, followed by reconstructive surgery. Small to moderate defects may be repaired with autologous or bovine pericardial patches, while larger defects necessitate a Dacron patch.<xref ref-type="bibr" rid="article-619.r22">[22]</xref>&#x000a0;An aortic homograft is preferred if more than 50% of the annulus is affected.<xref ref-type="bibr" rid="article-619.r23">[23]</xref>&#x000a0;Aortic root abscess presents a significant challenge due to the extensive damage it can inflict on nearby structures, including the fibrous trigones, interventricular septum, atria, and pulmonary artery.<xref ref-type="bibr" rid="article-619.r22">[22]</xref> The severity of the infection often necessitates complete replacement of the aortic root, coupled with reimplantation of the coronary arteries to restore functionality. In cases where intervalvular fibrosis is present, an aortic homograft is the preferred treatment option, offering a favorable outcome in complex reconstructions where standard prosthetic valves might not suffice.<xref ref-type="bibr" rid="article-619.r24">[24]</xref> This approach helps manage the infection while addressing the structural damage caused by the abscess. For prosthetic aortic valve endocarditis that spares the aortic root and annulus after radical resection, implanting a new prosthetic valve (tissue or mechanical) is reasonable (Class IIa).<xref ref-type="bibr" rid="article-619.r2">[2]</xref>&#x000a0;However, with the destruction of the annulus or if the infection has spread beyond the aortic root, reconstruction and using an allograft or a biologic tissue root is preferable to a prosthetic valved conduit (Class IIa).<xref ref-type="bibr" rid="article-619.r2">[2]</xref></p>
        <p>Annular abscesses are a serious complication of aortic valve endocarditis, occurring in 12% to 50% of cases and doubling short-term mortality rates. Recurrence of IE is also more frequent in patients with annular abscesses.<xref ref-type="bibr" rid="article-619.r4">[4]</xref> As such, eradicating the infection through radical surgical debridement followed by patch reconstruction is critical. While local antibiotics have been proposed to reduce the risk of recurrence, the likelihood of residual disease is low following complete surgical abscess removal. However, mixing antibiotics with fibrin glue in the remaining abscess cavity may only offer temporary protection, and the glue could hinder antibiotic penetration into surrounding tissues, reducing the treatment's effectiveness. Although local antibiotic application has successfully prevented sternal wound infections, developing antibiotic-eluting or bacteria-resistant patches and valve prostheses may offer a more robust solution to prevent recurrent endocarditis in this high-risk group.<xref ref-type="bibr" rid="article-619.r25">[25]</xref></p>
      </sec>
      <sec id="article-619.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for aortic valve endocarditis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nonbacterial thrombotic endocarditis
<list list-type="bullet"><list-item><p>Marantic endocarditis causes small sterile vegetations on the valve leaflets&#x000a0;and is linked to hypercoagulable states and some malignancies.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Libman&#x02013;Sacks endocarditis
<list list-type="bullet"><list-item><p>This condition causes verrucous vegetations and is associated with systemic lupus erythematosus.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Vasculitis</p>
          </list-item>
          <list-item>
            <p>Connective tissue disease</p>
          </list-item>
          <list-item>
            <p>Fever of unknown origin</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-619.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of IE is influenced by a myriad of factors, making it a challenging disease to manage and treat effectively. In-hospital mortality for IE has remained relatively stable over the past&#x000a0;2 decades, ranging&#x000a0;from&#x000a0;15%&#x000a0;to 30%, and various patient characteristics have been identified as contributing factors to this elevated risk of death. The overall in-hospital mortality is around 20%, whereas the 6-month mortality is approximately 30%, underscoring the fatal nature of this condition.<xref ref-type="bibr" rid="article-619.r26">[26]</xref>&#x000a0;The virulence of the causative organism, complications, patient comorbidities, and the timing of medical or surgical interventions largely determine prognostic outcomes.</p>
        <p>Causative organisms such as <italic toggle="yes">S aureus</italic>, <italic toggle="yes">Pseudomonas aeruginosa</italic>, Enterobacteriaceae, and fungi are associated with significantly higher mortality rates. Certain patient-specific factors also contribute to a poorer prognosis, including advanced age, prosthetic valve endocarditis, hemodialysis, severe heart failure, stroke, the presence of an intracardiac abscess, severe immunosuppression (eg, human immunodeficiency virus infection), or perivalvular extension with myocardial abscess formation.<xref ref-type="bibr" rid="article-619.r1">[1]</xref><xref ref-type="bibr" rid="article-619.r26">[26]</xref> Prosthetic valve endocarditis carries a worse prognosis compared to native valve endocarditis due to the increased risk of perivalvular complications and prosthetic valve dehiscence. Conversely, right-sided IE in intravenous drug users typically has a lower mortality rate, around 10%, reflecting the less complex nature of the disease in this subgroup.<xref ref-type="bibr" rid="article-619.r27">[27]</xref></p>
        <p>Despite technological advances in diagnostic imaging, antimicrobial therapy, and surgical techniques, the mortality rate for IE has not significantly decreased. This persistence is attributed to multiple factors, including the increasing age of affected patients, the higher prevalence of comorbid conditions, changing epidemiological trends, and the emergence of more resistant pathogens.<xref ref-type="bibr" rid="article-619.r1">[1]</xref><xref ref-type="bibr" rid="article-619.r26">[26]</xref> Nosocomial infections, often caused by multi-drug resistant organisms, now represent a greater proportion of IE cases, especially in developed countries. Additionally, the need for complex interventions in high-risk populations can contribute to elevated perioperative mortality and morbidity. Early&#x000a0;recognition of high-risk individuals could provide opportunities for timely interventions, such as urgent or emergency surgery, which may improve overall outcomes and long-term prognosis.<xref ref-type="bibr" rid="article-619.r4">[4]</xref></p>
      </sec>
      <sec id="article-619.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Cardiac complications include congestive heart failure caused by valvular damage from the infection, annular abscess, the extension of infection into the conduction system leading to atrioventricular blocks, mycotic aneurysms of the sinus of Valsalva, which can result in pericarditis, hemopericardium, and cardiac tamponade, or fistulas to the cardiac chambers including the right or left ventricle.<xref ref-type="bibr" rid="article-619.r1">[1]</xref>&#x000a0;Neurologic complications include thromboembolic events and mycotic aneurysms from septic embolization of vegetations; these aneurysms can rupture and cause intracranial hemorrhage and sudden death.<xref ref-type="bibr" rid="article-619.r1">[1]</xref> Other complications include systemic embolism to the end organs, including the liver, the lungs, the kidneys, and the spleen.<xref ref-type="bibr" rid="article-619.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-619.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Preventing IE relies on more than just antibiotic prophylaxis. Individuals at risk should be educated on the importance of maintaining proper dental and skin hygiene, recognizing signs of infection, and informing their healthcare provider about their risk if they experience an unexplained fever. In such cases, clinicians should consider screening for IE before starting antibiotic treatment. To enhance patient understanding, using simple language, visual aids, digital resources, repetition, and the teach-back method is highly recommended. National cardiology societies are encouraged to create specific IE awareness cards to educate patients.<xref ref-type="bibr" rid="article-619.r28">[28]</xref>&#x000a0;Early recognition and diagnosis of&#x000a0;IE are imperative to ensure timely management and optimal clinical outcomes.&#x000a0;Identifying patients who are surgical candidates is essential, as early surgical intervention is associated with lower mortality.<xref ref-type="bibr" rid="article-619.r29">[29]</xref></p>
      </sec>
      <sec id="article-619.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key insights for aortic valve endocarditis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>IE predominantly affects men around the age of 60.</p>
          </list-item>
          <list-item>
            <p>There is a higher prevalence of prosthetic valve IE, cardiovascular device-related IE, nosocomial infections, and those caused by <italic toggle="yes">Staphylococcus</italic> and <italic toggle="yes">Enterococcus</italic> species.</p>
          </list-item>
          <list-item>
            <p>Oral streptococcal endocarditis remains less common, and its incidence has not risen following the 2009 and 2015 guidelines limiting antibiotic prophylaxis use.</p>
          </list-item>
          <list-item>
            <p>Advanced imaging techniques, such as fluorodeoxyglucose F 18-PET-CT, have gained global usage in diagnosing IE.</p>
          </list-item>
          <list-item>
            <p>The use of mechanical valve replacements is declining, while mitral valve repair remains underutilized in IE cases.</p>
          </list-item>
          <list-item>
            <p>Despite advancements, the prognosis for IE remains poor, highlighting the need for more aggressive treatment approaches.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-619.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Infective endocarditis (IE) is a serious condition with a grave prognosis. Despite technological advances over the past few decades, which have helped improve the diagnosis and management of IE, its mortality remains high. Results from several observational studies have highlighted the critical role of a dedicated endocarditis team in improving the diagnosis, management, and clinical outcomes of patients with IE.<xref ref-type="bibr" rid="article-619.r30">[30]</xref><xref ref-type="bibr" rid="article-619.r31">[31]</xref> As the European Society of Cardiology and the American College of Cardiology/American Heart Association recommended, multidisciplinary endocarditis teams have led to more timely and accurate diagnoses of the disease and its complications, consistent antibiotic therapy, and better surgical intervention timing.<xref ref-type="bibr" rid="article-619.r32">[32]</xref><xref ref-type="bibr" rid="article-619.r33">[33]</xref></p>
        <p>A multidisciplinary approach is essential given the varied clinical presentations of IE, which depend on patient characteristics and the microorganism's virulence. The endocarditis team must be flexible, adapting to the patient's specific clinical needs and local epidemiology to ensure efficient diagnosis and treatment.&#x000a0;The endocarditis team should comprise specialists directly involved in the diagnosis and treatment, with the composition varying based on the type of healthcare facility. Key members of the team include cardiologists and surgeons experienced in cardiovascular implanted electronic device extraction, heart failure, and congenital heart disease. Additional essential team members include pathologists, critical care specialists, cardiac anesthesiologists, interventional cardiologists, neurologists, neurosurgeons, pharmacologists, radiologists, nuclear medicine specialists, nephrologists, and geriatricians. Multidisciplinary addiction medicine teams&#x02014;composed of psychiatrists, nurses, and social workers&#x02014;are also vital for counseling and should be available for consultation.<xref ref-type="bibr" rid="article-619.r6">[6]</xref></p>
      </sec>
      <sec id="article-619.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=619&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=619">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/aortic-valve-endocarditis-surgical-treatment/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=619">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/619/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=619">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-619.s16">
        <title>References</title>
        <ref id="article-619.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mylonakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Infective endocarditis in adults.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Nov</month>
            <day>01</day>
            <volume>345</volume>
            <issue>18</issue>
            <fpage>1318</fpage>
            <page-range>1318-30</page-range>
            <pub-id pub-id-type="pmid">11794152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs</collab>
              <name>
                <surname>Pettersson</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Coselli</surname>
                <given-names>JS</given-names>
              </name>
              <collab>Writing Committee</collab>
              <name>
                <surname>Pettersson</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Coselli</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>LeMaire</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Woc-Colburn</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>153</volume>
            <issue>6</issue>
            <fpage>1241</fpage>
            <page-range>1241-1258.e29</page-range>
            <pub-id pub-id-type="pmid">28365016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Momtazmanesh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saeedi Moghaddam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malakan Rad</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Azadnajafabad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ebrahimi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mohammadi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rouhifard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Masinaei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Keykhaei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aminorroaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghamari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Larijani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Farzadfar</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019.</article-title>
            <source>Eur J Prev Cardiol</source>
            <year>2022</year>
            <month>May</month>
            <day>27</day>
            <volume>29</volume>
            <issue>8</issue>
            <fpage>1287</fpage>
            <page-range>1287-1297</page-range>
            <pub-id pub-id-type="pmid">34897404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Donal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cosyns</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Laroche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sadeghpour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vaskelyte</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Sow</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Axler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maggioni</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <collab>EURO-ENDO Investigators</collab>
            </person-group>
            <article-title>Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.</article-title>
            <source>Eur Heart J</source>
            <year>2019</year>
            <month>Oct</month>
            <day>14</day>
            <volume>40</volume>
            <issue>39</issue>
            <fpage>3222</fpage>
            <page-range>3222-3232</page-range>
            <pub-id pub-id-type="pmid">31504413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haidari</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Knipp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Turaev</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>El Gabry</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Aortic Valve Infective Endocarditis Complicated by Annular Abscess: Antibiotics in the Abscess Cavity.</article-title>
            <source>J Cardiovasc Dev Dis</source>
            <year>2024</year>
            <month>Jun</month>
            <day>24</day>
            <volume>11</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">39057612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ajmone Marsan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Waha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonaros</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Caselli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doenst</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ederhy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Foldager</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fosb&#x000f8;l</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Kovac</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mestres</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>OI</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Pazdernik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pizzi</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Risti&#x00107;</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s-Cabau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sionis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Z&#x000fc;hlke</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>2023 ESC Guidelines for the management of endocarditis.</article-title>
            <source>Eur Heart J</source>
            <year>2023</year>
            <month>Oct</month>
            <day>14</day>
            <volume>44</volume>
            <issue>39</issue>
            <fpage>3948</fpage>
            <page-range>3948-4042</page-range>
            <pub-id pub-id-type="pmid">37622656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGiffin</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kirklin</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Reconstructing the infected aortic root with antibiotic impregnated biological glue.</article-title>
            <source>J Card Surg</source>
            <year>2014</year>
            <month>May</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>340</fpage>
            <page-range>340-2</page-range>
            <pub-id pub-id-type="pmid">24433228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baddour</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Tleyjeh</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Rybak</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Barsic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Gewitz</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Levison</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bolger</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Steckelberg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baltimore</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taubert</surname>
                <given-names>KA</given-names>
              </name>
              <collab>American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council</collab>
            </person-group>
            <article-title>Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Oct</month>
            <day>13</day>
            <volume>132</volume>
            <issue>15</issue>
            <fpage>1435</fpage>
            <page-range>1435-86</page-range>
            <pub-id pub-id-type="pmid">26373316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Goyal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chhabra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Parekh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhyan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khalid</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <chapter-title>Minimally Invasive Aortic Valve Surgery</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">29261951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regueiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Linke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Latib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ihlemann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Urena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walther</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Husser</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Nombela-Franco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cheema</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Le Breton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stortecky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bartorelli</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Sinning</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Amat-Santos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Munoz-Garcia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lerakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez-Ibanes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Abdel-Wahab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tchetche</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Testa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eltchaninoff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Livi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Jilaihawi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Barbanti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kodali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Brito</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Miceli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fiorina</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dato</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Rosato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Serra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Masson</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Wijeysundera</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Abizaid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marino</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Esteves</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Andrea</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Messika-Zeitoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Himbert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Auffret</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nietlispach</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pilgrim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Durand</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lisko</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Makkar</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Lemos</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Puri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>San Roman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>S&#x000f8;ndergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mangner</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s-Cabau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Sep</month>
            <day>13</day>
            <volume>316</volume>
            <issue>10</issue>
            <fpage>1083</fpage>
            <page-range>1083-92</page-range>
            <pub-id pub-id-type="pmid">27623462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sadeghpour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meshaal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sambola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Furnaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Citro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ternacle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Donal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cosyns</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Laroche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pazdernik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maggioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gale</surname>
                <given-names>CP</given-names>
              </name>
              <collab>EURO-ENDO Investigators</collab>
            </person-group>
            <article-title>The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.</article-title>
            <source>Eur Heart J Qual Care Clin Outcomes</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-207</page-range>
            <pub-id pub-id-type="pmid">30957862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwiebert</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baig</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sandoe</surname>
                <given-names>JAT</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of splinter haemorrhages in patients referred for suspected infective endocarditis.</article-title>
            <source>Heart</source>
            <year>2022</year>
            <month>Jul</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">35842232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grable</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ulhaq</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Banchs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of infective endocarditis in a cancer population.</article-title>
            <source>Open Heart</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">34344722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>N'Guyen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Revest</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erpelding</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Selton-Suty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bouchiat</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Delahaye</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chirouze</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Strady</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hoen</surname>
                <given-names>B</given-names>
              </name>
              <collab>AEPEI study group</collab>
            </person-group>
            <article-title>Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis.</article-title>
            <source>Ann Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>117</fpage>
            <page-range>117-125</page-range>
            <pub-id pub-id-type="pmid">27607562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gaemperli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rouzet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hacker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Signore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Slart</surname>
                <given-names>RHJA</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Recommendations on nuclear and multimodality imaging in IE and CIED infections.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>1795</fpage>
            <page-range>1795-1815</page-range>
            <pub-id pub-id-type="pmid">29799067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Skubas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brindis</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Creager</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>DeMets</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hochman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ohman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Pressler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sellke</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <collab>American College of Cardiology</collab>
              <collab>American College of Cardiology/American Heart Association</collab>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>148</volume>
            <issue>1</issue>
            <fpage>e1</fpage>
            <page-range>e1-e132</page-range>
            <pub-id pub-id-type="pmid">24939033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Durack</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lukes</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Bright</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.</article-title>
            <source>Am J Med</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>200</fpage>
            <page-range>200-9</page-range>
            <pub-id pub-id-type="pmid">8154507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Mick</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nettles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bashore</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>633</fpage>
            <page-range>633-8</page-range>
            <pub-id pub-id-type="pmid">10770721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guittet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hamon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comparative Value of Cardiac CT and Transesophageal Echocardiography in Infective Endocarditis: A Systematic Review and Meta-Analysis.</article-title>
            <source>Radiol Cardiothorac Imaging</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>e190189</fpage>
            <pub-id pub-id-type="pmid">33778583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Ouazzani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jandou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Christophe Thuaire</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Thrombus or vegetation?Importance of cardiac MRI as a diagnostic tool based on case report and literature review.</article-title>
            <source>Ann Med Surg (Lond)</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>60</volume>
            <fpage>690</fpage>
            <page-range>690-694</page-range>
            <pub-id pub-id-type="pmid">33318794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzi</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Roque</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Hidalgo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cu&#x000e9;llar-Calabria</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ferreira-Gonz&#x000e1;lez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e0;lez-Alujas</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Oristrell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gracia-S&#x000e1;nchez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Palomares</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gali&#x000f1;anes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maisterra-Santos</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Garcia-Dorado</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Castell-Conesa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aguad&#x000e9;-Bruix</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Sep</month>
            <day>22</day>
            <volume>132</volume>
            <issue>12</issue>
            <fpage>1113</fpage>
            <page-range>1113-26</page-range>
            <pub-id pub-id-type="pmid">26276890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>d'Udekem</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Feindel</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of operation for paravalvular abscess.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-53</page-range>
            <pub-id pub-id-type="pmid">8678685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yankah</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Pasic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klose</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Siniawski</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hetzer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-75</page-range>
            <pub-id pub-id-type="pmid">15982588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knosalla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yankah</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Siniawski</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hofmeister</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hammerschmidt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Loebe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hetzer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess--11 year results.</article-title>
            <source>Eur Heart J</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>490</fpage>
            <page-range>490-7</page-range>
            <pub-id pub-id-type="pmid">10681490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andreas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muckenhuber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hutschala</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kocher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thalhammer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vogt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fleck</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Laufer</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Direct sternal administration of Vancomycin and Gentamicin during closure prevents wound infection.</article-title>
            <source>Interact Cardiovasc Thorac Surg</source>
            <year>2017</year>
            <month>Jul</month>
            <day>01</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-11</page-range>
            <pub-id pub-id-type="pmid">28402472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gaca</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Management Considerations in Infective Endocarditis: A Review.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Jul</month>
            <day>03</day>
            <volume>320</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-83</page-range>
            <pub-id pub-id-type="pmid">29971402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hecht</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes.</article-title>
            <source>Ann Intern Med</source>
            <year>1992</year>
            <month>Oct</month>
            <day>01</day>
            <volume>117</volume>
            <issue>7</issue>
            <fpage>560</fpage>
            <page-range>560-6</page-range>
            <pub-id pub-id-type="pmid">1524330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cosby</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boyko</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hatton-Bauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Turnbull</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations.</article-title>
            <source>J Cancer Educ</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-21</page-range>
            <pub-id pub-id-type="pmid">21161465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Skoutelis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lejko-Zupa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bouza</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tattevin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Altclas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Edathodu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fortes</surname>
                <given-names>CQ</given-names>
              </name>
              <name>
                <surname>Siciliano</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Pachirat</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kanj</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <collab>International Collaboration on Endocarditis (ICE) Investigators</collab>
            </person-group>
            <article-title>Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2016</year>
            <month>Apr</month>
            <day>18</day>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>e003016</fpage>
            <pub-id pub-id-type="pmid">27091179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ebisawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arakawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kusuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohji</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Impact of Infectious Disease Consultation on Management and Outcomes of Infective Endocarditis.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>112</volume>
            <issue>4</issue>
            <fpage>1228</fpage>
            <page-range>1228-1234</page-range>
            <pub-id pub-id-type="pmid">33248990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Dalati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cronin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riddell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Washer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stoneman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Murali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fagan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chanderraj</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Christine</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ressler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fukuhara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deeb</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>The Clinical Impact of Implementation of a Multidisciplinary Endocarditis Team.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>118</fpage>
            <page-range>118-124</page-range>
            <pub-id pub-id-type="pmid">33662308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blomstr&#x000f6;m-Lundqvist</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Traykov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bongiorni</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deharo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Saghy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Snygg-Martin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Starck</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tascini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strathmore</surname>
                <given-names>N</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).</article-title>
            <source>Europace</source>
            <year>2020</year>
            <month>Apr</month>
            <day>01</day>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>515</fpage>
            <page-range>515-549</page-range>
            <pub-id pub-id-type="pmid">31702000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-619.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Bin Mahmood</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Geirsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mangi</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Trends in Infective Endocarditis Hospitalizations, Characteristics, and Valve Operations in Patients With Opioid Use Disorders in the United States: 2005-2014.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2020</year>
            <month>Mar</month>
            <day>17</day>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e012465</fpage>
            <pub-id pub-id-type="pmid">32172645</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
